Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junya Fujita

Showing results (41-50 of 95) with videos related to

Pageof 10
Sort By:
In Vivo (Athens, Greece)|December 28, 2018
Response to First-line Recurrence Treatment Influences Survival in Hormone Receptor-positive, HER2-negative Breast Cancer: A Multicenter StudyJun Yamamura, Shunji Kamigaki, Masaki Tsujie, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|November 1, 2019
Five-year outcomes of a phase II study of adjuvant chemotherapy with S-1 plus docetaxel for stage III gastric cancer after curative D2 gastrectomy (OGSG1002)Kazumasa Fujitani, Shigeyuki Tamura, Yutaka Kimura, et al.
The Lancet. Gastroenterology & Hepatology|January 28, 2021
Safety and activity of trifluridine/tipiracil and ramucirumab in previously treated advanced gastric cancer: an open-label, single-arm, phase 2 trialAkihito Kawazoe, Takayuki Ando, Hisashi Hosaka, et al.
Kyobu Geka. the Japanese Journal of Thoracic Surgery|April 10, 2012
[Abdominal lymph node metastases detected five years after surgery for the lung cancer; report of a case]Noriyuki Watanabe, Takashi Iwazawa, Kennichi Nagai, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 4, 2015
[A case of curatively resected advanced intrahepatic cholangiocellular carcinoma through effective response to neoadjuvant chemotherapy]Kazuhiko Hashimoto, Takeshi Tono, Kentaro Nishida, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 23, 2014
[Adjuvant therapy with WT1 peptide-pulsed dendritic cell therapy in combination with TS-1 for pancreatic cancer with positive peritoneal cytology after curative operation]Kazuhiko Hashimoto, Takeshi Tono, Hirofumi Abe, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 27, 2012
[Complications associated with the placement of subcutaneous central venous access port devices: reasons for removal and complications observed]Katsuki Danno, Tadashi Ohnishi, Ami Watanabe, et al.
Journal of Surgical Oncology|October 25, 2013
Prognostic information derived from RT-PCR analysis of peritoneal fluid in gastric cancer patients: results from a prospective multicenter clinical trialShigeyuki Tamura, Yoshiyuki Fujiwara, Yutaka Kimura, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 17, 2026
[Investigation of the Relationship between Nutritional Indicators and Prognosis in Cancer Patients Undergoing CV Port Placement for Palliative and Nutritional Purposes]Yoshiki Taniguchi, Toru Masuzawa, Junya Fujita, et al.
Surgery Today|May 20, 2014
Randomized controlled trial of the LigaSure vessel sealing system versus conventional open gastrectomy for gastric cancerJunya Fujita, Shuji Takiguchi, Kazuhiro Nishikawa, et al.
Pageof 10

Showing results (41-50 of 95) with videos related to

Sort By:
Pageof 10
In Vivo (Athens, Greece)|December 28, 2018
Response to First-line Recurrence Treatment Influences Survival in Hormone Receptor-positive, HER2-negative Breast Cancer: A Multicenter StudyJun Yamamura, Shunji Kamigaki, Masaki Tsujie, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|November 1, 2019
Five-year outcomes of a phase II study of adjuvant chemotherapy with S-1 plus docetaxel for stage III gastric cancer after curative D2 gastrectomy (OGSG1002)Kazumasa Fujitani, Shigeyuki Tamura, Yutaka Kimura, et al.
The Lancet. Gastroenterology & Hepatology|January 28, 2021
Safety and activity of trifluridine/tipiracil and ramucirumab in previously treated advanced gastric cancer: an open-label, single-arm, phase 2 trialAkihito Kawazoe, Takayuki Ando, Hisashi Hosaka, et al.
Kyobu Geka. the Japanese Journal of Thoracic Surgery|April 10, 2012
[Abdominal lymph node metastases detected five years after surgery for the lung cancer; report of a case]Noriyuki Watanabe, Takashi Iwazawa, Kennichi Nagai, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 4, 2015
[A case of curatively resected advanced intrahepatic cholangiocellular carcinoma through effective response to neoadjuvant chemotherapy]Kazuhiko Hashimoto, Takeshi Tono, Kentaro Nishida, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 23, 2014
[Adjuvant therapy with WT1 peptide-pulsed dendritic cell therapy in combination with TS-1 for pancreatic cancer with positive peritoneal cytology after curative operation]Kazuhiko Hashimoto, Takeshi Tono, Hirofumi Abe, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 27, 2012
[Complications associated with the placement of subcutaneous central venous access port devices: reasons for removal and complications observed]Katsuki Danno, Tadashi Ohnishi, Ami Watanabe, et al.
Journal of Surgical Oncology|October 25, 2013
Prognostic information derived from RT-PCR analysis of peritoneal fluid in gastric cancer patients: results from a prospective multicenter clinical trialShigeyuki Tamura, Yoshiyuki Fujiwara, Yutaka Kimura, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 17, 2026
[Investigation of the Relationship between Nutritional Indicators and Prognosis in Cancer Patients Undergoing CV Port Placement for Palliative and Nutritional Purposes]Yoshiki Taniguchi, Toru Masuzawa, Junya Fujita, et al.
Surgery Today|May 20, 2014
Randomized controlled trial of the LigaSure vessel sealing system versus conventional open gastrectomy for gastric cancerJunya Fujita, Shuji Takiguchi, Kazuhiro Nishikawa, et al.
Pageof 10